Literature DB >> 14690792

Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index.

Martha L Slattery1, Bette J Caan, Joan Benson, Maureen Murtaugh.   

Abstract

Lack of energy balance, or greater energy intake than expenditure as indicated by a large body mass index (BMI), has been associated with colon cancer, although less is known about its association with rectal cancer. In this study, we examined the association between BMI, energy intake, and energy expenditure and their combined effect on rectal cancer risk. A population-based case-control study was conducted in Utah and Northern California. Incident cases (n = 952) of rectal cancer and population-based controls (n = 1205) were interviewed between 1997 and 2002 to obtain detailed information on body size, dietary intake, and physical activity patterns. BMI (kg/m(2)) was not associated with rectal cancer in either men or women. Participation in vigorous leisure-time physical activity over the past 20 yr was associated with a significant 40% reduction in rectal cancer risk. Energy intake was associated significantly with increased risk of rectal cancer, especially among people whose diagnosis was prior to age 60 yr (odds ratio [OR] = 3.9; 95% confidence interval [CI] = 1.7-9.1 for men; OR = 2.8; 95% CI = 1.1-7.2 for women). There was a significant interaction between energy intake and energy expenditure, although not between BMI and either energy intake or energy expenditure. These data suggest that large BMI, an indicator of lack of energy balance, is not an important component of the etiology of rectal cancer. However, both physical activity and energy intake were significantly associated with rectal cancer risk. These data suggest that energy expenditure and energy intake alter rectal cancer risk through mechanisms other than energy balance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14690792     DOI: 10.1207/S15327914NC4602_09

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  48 in total

1.  COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.

Authors:  Karen W Makar; Elizabeth M Poole; Alexa J Resler; Brenna Seufert; Karen Curtin; Sarah E Kleinstein; David Duggan; Richard J Kulmacz; Li Hsu; John Whitton; Christopher S Carlson; Christine F Rimorin; Bette J Caan; John A Baron; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Cancer Causes Control       Date:  2013-12       Impact factor: 2.506

2.  The miRNA landscape of colorectal polyps.

Authors:  Martha L Slattery; Jennifer S Herrick; Roger K Wolff; Lila E Mullany; John R Stevens; Wade Samowitz
Journal:  Genes Chromosomes Cancer       Date:  2017-02-01       Impact factor: 5.006

3.  Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.

Authors:  Martha L Slattery; Jennifer S Herrick; Abbie Lundgreen; Francis A Fitzpatrick; Karen Curtin; Roger K Wolff
Journal:  Carcinogenesis       Date:  2010-07-09       Impact factor: 4.944

4.  Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes.

Authors:  Martha L Slattery; Karen Curtin; Roger K Wolff; Jennifer S Herrick; Bette J Caan; Wade Samowitz
Journal:  Cancer Causes Control       Date:  2010-04-10       Impact factor: 2.506

5.  MAP kinase genes and colon and rectal cancer.

Authors:  Martha L Slattery; Abbie Lundgreen; Roger K Wolff
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

6.  A meta-analysis of the effects of energy intake on risk of digestive cancers.

Authors:  Xiao-Feng Yu; Yi-Qian Wang; Jian Zou; Jie Dong
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.

Authors:  Clare Abbenhardt; Elizabeth M Poole; Richard J Kulmacz; Liren Xiao; Karen Curtin; Rachel L Galbraith; David Duggan; Li Hsu; Karen W Makar; Bette J Caan; Lisel Koepl; Robert W Owen; Dominique Scherer; Christopher S Carlson; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

8.  An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality.

Authors:  Martha L Slattery; Jennifer S Herrick; Lila E Mullany; Nicola Valeri; John Stevens; Bette J Caan; Wade Samowitz; Roger K Wolff
Journal:  Int J Cancer       Date:  2014-12-16       Impact factor: 7.396

9.  Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors.

Authors:  Carol Sweeney; Kenneth M Boucher; Wade S Samowitz; Roger K Wolff; Hans Albertsen; Karen Curtin; Bette J Caan; Martha L Slattery
Journal:  Genes Chromosomes Cancer       Date:  2009-01       Impact factor: 5.006

10.  A comparison of colon and rectal somatic DNA alterations.

Authors:  Martha L Slattery; Karen Curtin; Roger K Wolff; Kenneth M Boucher; Carol Sweeney; Sandra Edwards; Bette J Caan; Wade Samowitz
Journal:  Dis Colon Rectum       Date:  2009-07       Impact factor: 4.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.